The effects of hemocyanin on T cells cultured in vitro

As a broad-spectrum antibiotic, gentamicin is used extensively in T cell culturing , but preliminary studies have identified that T cell activity is significantly affected by gentamicin. In the present study, the hemocyanin from ( ) was selected as an additive for T cell cultures . Compared with tho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncology letters 2018-02, Vol.15 (2), p.2655-2660
Hauptverfasser: Liu, Jiani, Chen, Cong, Ling, Chen, Hu, Haoyun, Cao, Jingsong, Gao, Yongqiang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:As a broad-spectrum antibiotic, gentamicin is used extensively in T cell culturing , but preliminary studies have identified that T cell activity is significantly affected by gentamicin. In the present study, the hemocyanin from ( ) was selected as an additive for T cell cultures . Compared with those in the control group, the cell quantity exhibited no significant difference, and the formation rate of cell colony increased gradually with increases in the hemocyanin concentration. Additionally, flow cytometry assays identified that cluster of differentiation (CD)3 CD4 and CD4 CD25 T cells in the 0.2 µg/ml hemocyanin (Hem 3) group were all significantly increased. Furthermore, cell cycle analysis demonstrated that T cells in the G0/G1 phase were significantly decreased in the Hem 3 group compared with in the control, 0.05 µg/ml (Hem 1) and 0.1 µg/ml (Hem 2) groups, and cells in the S phase were significantly elevated in the Hem 3 group compared with in the control and Hem 1 groups. In addition, MTT analysis indicated that the cytotoxicity of T cells towards HepG2 cells was significantly increased in the Hem 3 group compared with in the control, Hem 1 and Hem 2 groups. Taken together, the present study identified that hemocyanin may improve the proliferation and cytotoxicity of T cells, and the results supported the use of hemocyanin in T cell adoptive immunotherapy.
ISSN:1792-1074
1792-1082
DOI:10.3892/ol.2017.7587